Delcath Systems (NSDQ:DCTH) said today that doctors in Europe performed the 500th percutaneous hepatic perfusion therapy treatment using Delcath’s Chemosat delivery system.
The drug-device combo has been available in certain European markets since 2012.
Get the full story at our sister site, Drug Delivery Business News.